Article Text

other Versions

PDF
Letter
Hepatitis B virus seromarkers clearance and risk of hepatocellular carcinoma: serious risks of misinterpretation
  1. Alexandre Pariente
  1. Correspondence to Dr Alexandre Pariente, Unité d'hépatogastroentérologie, Centre Hospitalier, Boulevard Hauterive, Pau 64000, France; alex.pariente{at}free.fr

Statistics from Altmetric.com

Liu et al1 have to be commended for their recent report concerning the predictive value of hepatitis B virus (HBV) seromarkers clearance for hepatocellular carcinoma (HCC) risk in the REVEAL study. There are, however, some limits and interrogations:

  • The incidence rates of HCC are measured from baseline (as the characteristics of the patients) and not from …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles